Screening for sensitivity towards vincristine and doxorubicin in a newly established B-cell cancer cell line panel revealed great variability in the dose resulting in 50% growth inhibition (GI50)

Kirsten Fogd; Martin Bøgsted; Steffen Falgreen Larsen; H Høholt; Ann-Maria Jensen; L H Madsen; Mette Nyegaard; Suzette Sørensen; J M Holst; Alexander Schmitz; Hans Erik Johnsen; Karen Dybkær

Screening for sensitivity towards vincristine and doxorubicin in a newly established B-cell cancer cell line panel revealed great variability in the dose resulting in 50% growth inhibition (GI50)

Kirsten Fogd, Martin Bøgsted, Steffen Falgreen Larsen, H Høholt, Ann-Maria Jensen, L H Madsen, Mette Nyegaard, Suzette Sørensen, J M Holst, Alexander Schmitz, Hans Erik Johnsen, Karen Dybkær

Research output: Contribution to conference without publisher/journal › Conference abstract for conference › Research

Original language	English
Publication date	2010
Publication status	Published - 2010
Externally published	Yes
Event	Forskningens Dag 2010 - Aalborg Sygehus - Aalborg Duration: 28 Oct 2010 → 28 Oct 2010

Conference

Conference	Forskningens Dag 2010 - Aalborg Sygehus
City	Aalborg
Period	28/10/2010 → 28/10/2010

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Fogd, K., Bøgsted, M., Larsen, S. F., Høholt, H., Jensen, A.-M., Madsen, L. H., Nyegaard, M., Sørensen, S., Holst, J. M., Schmitz, A., Johnsen, H. E., & Dybkær, K. (2010). Screening for sensitivity towards vincristine and doxorubicin in a newly established B-cell cancer cell line panel revealed great variability in the dose resulting in 50% growth inhibition (GI50). Abstract from Forskningens Dag 2010 - Aalborg Sygehus, Aalborg.

@conference{f62804c21a09400c9cc09600fc68e3f1,

title = "Screening for sensitivity towards vincristine and doxorubicin in a newly established B-cell cancer cell line panel revealed great variability in the dose resulting in 50% growth inhibition (GI50)",

author = "Kirsten Fogd and Martin B{\o}gsted and Larsen, {Steffen Falgreen} and H H{\o}holt and Ann-Maria Jensen and Madsen, {L H} and Mette Nyegaard and Suzette S{\o}rensen and Holst, {J M} and Alexander Schmitz and Johnsen, {Hans Erik} and Karen Dybk{\ae}r",

year = "2010",

language = "English",

note = "Forskningens Dag 2010 - Aalborg Sygehus ; Conference date: 28-10-2010 Through 28-10-2010",

}

Fogd, K, Bøgsted, M, Larsen, SF, Høholt, H, Jensen, A-M, Madsen, LH, Nyegaard, M, Sørensen, S, Holst, JM, Schmitz, A, Johnsen, HE & Dybkær, K 2010, 'Screening for sensitivity towards vincristine and doxorubicin in a newly established B-cell cancer cell line panel revealed great variability in the dose resulting in 50% growth inhibition (GI50)', Forskningens Dag 2010 - Aalborg Sygehus, Aalborg, 28/10/2010 - 28/10/2010.

Screening for sensitivity towards vincristine and doxorubicin in a newly established B-cell cancer cell line panel revealed great variability in the dose resulting in 50% growth inhibition (GI50). / Fogd, Kirsten; Bøgsted, Martin; Larsen, Steffen Falgreen et al.
2010. Abstract from Forskningens Dag 2010 - Aalborg Sygehus, Aalborg.

Research output: Contribution to conference without publisher/journal › Conference abstract for conference › Research

TY - ABST

T1 - Screening for sensitivity towards vincristine and doxorubicin in a newly established B-cell cancer cell line panel revealed great variability in the dose resulting in 50% growth inhibition (GI50)

AU - Fogd, Kirsten

AU - Bøgsted, Martin

AU - Larsen, Steffen Falgreen

AU - Høholt, H

AU - Jensen, Ann-Maria

AU - Madsen, L H

AU - Nyegaard, Mette

AU - Sørensen, Suzette

AU - Holst, J M

AU - Schmitz, Alexander

AU - Johnsen, Hans Erik

AU - Dybkær, Karen

PY - 2010

Y1 - 2010

M3 - Conference abstract for conference

T2 - Forskningens Dag 2010 - Aalborg Sygehus

Y2 - 28 October 2010 through 28 October 2010

ER -